UBS Group
SOLV icon

UBS Group’s Solventum SOLV Stock Holding History

UBS Group’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,200
Closed -$254K – 11316
2025
Q4 		$254K Sell
3,200
-10,000
-76% -$766K ﹤0.01% 6458
2025
Q3 		$964K Buy
+13,200
New +$968K ﹤0.01% 5606

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group's SOLV Position: Q1 2026 in Review

UBS Group reduced its Solventum (SOLV) stake by 15% in Q1 2026, selling an estimated $8.53M and leaving 632,974 shares worth $41.3M. The position accounts for 0.01% of the portfolio, ranked #1839.

UBS Group first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $59.3M in Q4 2025. 878 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • UBS Group held 632,974 shares of Solventum worth $41.3M as of Q1 2026.
  • UBS Group sold 114,898 Solventum shares in Q1 2026, an estimated $8.53M.
  • Solventum made up 0.01% of UBS Group's portfolio in Q1 2026, its #1839 holding.
  • UBS Group first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • UBS Group's Solventum position peaked at $59.3M in Q4 2025.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.